🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

393,17 USD

Máx. histórico

447,03

14 días

Split 2:1 del 22/11/1999

Caída desde máximo

-12,05%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-10,08%

Cierre anterior

437,23

Rango de hoy

391,17 – 410,03

Volumen hoy

6.589.429

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
24,44 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,53%
Fecha de pago Importe por participación
16/11/2022 1,9400 USD
17/08/2022 1,9400 USD
16/05/2022 1,9400 USD
14/02/2022 1,9400 USD
15/11/2021 1,7600 USD
16/08/2021 1,7600 USD
14/05/2021 1,7600 USD
11/02/2021 1,7600 USD
13/11/2020 1,6000 USD
14/08/2020 1,6000 USD
15/05/2020 1,6000 USD
13/02/2020 1,6000 USD
14/11/2019 1,4500 USD
14/08/2019 1,4500 USD
16/05/2019 1,4500 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/08/2002 42,92 44,59 42,65 44,23 +4,76% 4,52% 16.463.400
05/08/2002 43,20 44,08 41,98 42,22 -2,96% 4,86% 15.115.000
02/08/2002 43,61 44,61 42,61 43,51 +0,25% 4,59% 15.541.900
01/08/2002 45,79 45,86 43,30 43,40 -4,91% 5,59% 15.863.800
31/07/2002 42,98 46,50 42,95 45,64 +0,33% 8,26% 33.644.300
30/07/2002 43,41 46,65 43,36 45,49 +3,34% 7,58% 25.061.100
29/07/2002 43,80 44,25 42,50 44,02 +1,48% 4,00% 20.937.900
26/07/2002 41,79 43,38 40,77 43,38 +3,43% 6,25% 17.267.000
25/07/2002 40,61 42,35 40,29 41,94 +13,08% 5,07% 43.226.100
24/07/2002 34,70 39,55 34,21 37,09 +4,19% 15,39% 26.174.100
23/07/2002 35,38 36,10 34,79 35,60 +0,91% 3,70% 27.637.600
22/07/2002 35,83 36,90 35,27 35,28 -0,51% 4,55% 24.249.200
19/07/2002 34,05 35,82 33,40 35,46 +3,44% 7,11% 27.505.200
18/07/2002 36,69 36,74 33,90 34,28 -7,60% 7,74% 21.493.800
17/07/2002 34,94 37,12 34,87 37,10 +12,87% 6,44% 29.001.900
16/07/2002 31,21 34,63 31,18 32,87 +5,79% 11,05% 37.426.600
15/07/2002 33,76 33,76 30,57 31,07 -9,42% 9,45% 26.714.600
12/07/2002 34,92 35,48 33,33 34,30 -0,32% 6,16% 16.552.100
11/07/2002 32,46 34,59 32,25 34,41 +5,78% 7,21% 20.980.500
10/07/2002 35,05 35,12 32,49 32,53 -6,87% 7,50% 18.911.800
09/07/2002 36,47 36,96 34,55 34,93 -3,53% 6,61% 12.951.300
08/07/2002 38,00 38,07 36,17 36,21 -4,89% 5,00% 12.180.600
05/07/2002 36,56 38,18 36,48 38,07 +6,25% 4,65% 6.473.100
03/07/2002 36,58 36,75 34,39 35,83 -3,03% 6,45% 19.835.500
02/07/2002 38,43 38,50 36,64 36,95 -3,68% 4,84% 17.464.400
01/07/2002 41,45 41,57 38,34 38,36 -8,40% 7,79% 16.032.300
28/06/2002 41,57 43,00 41,26 41,88 +0,94% 4,19% 13.014.300
27/06/2002 41,50 41,85 40,48 41,49 +1,67% 3,30% 14.872.900
26/06/2002 39,08 41,49 39,00 40,81 +0,37% 6,37% 19.021.000
25/06/2002 42,15 42,50 40,25 40,66 -2,68% 5,34% 15.075.400